Hagino Hiroshi
Rehabilitation Division, Tottori University Hospital.
Clin Calcium. 2004 Oct;14(10):111-3.
There is evidence that raloxifene prevents vertebral fracture and it improves bone metabolism in patients with osteoporosis to the normal pre-menopausal level. Therefore, it is suitable to use for osteoporotic patients with adequate physical activity and those improvable by exercise. Patients who will be treated by anabolic agents are also good candidates for the treatment of raloxifene.
有证据表明，雷洛昔芬可预防椎体骨折，并将骨质疏松症患者的骨代谢改善至绝经前的正常水平。因此，它适用于有足够体力活动的骨质疏松症患者以及那些可通过运动改善病情的患者。将接受合成代谢药物治疗的患者也是雷洛昔芬治疗的良好候选者。
